Table of Content


FIGURES AND TABLES
PART 1. INTRODUCTION
? Report description
? Objectives of the study
? Market segment
? Years considered for the report
? Currency
? Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
? Introduction
? Drivers
? Restraints
? Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY BRAND
? Genotropin
? Humatrope
? Norditropin
? Omnitrope
? Saizen
? Others
PART 6. MARKET BREAKDOWN BY ROUTE OF ADMINISTRATION
? Intramuscular
? Intravenous
? Subcutaneous
PART 7. MARKET BREAKDOWN BY DISTRIBUTION CHANNEL
? E-commerce
? Hospital & clinics
? Pharmacies & drug stores
PART 8. MARKET BREAKDOWN BY APPLICATION
? Adult growth hormone deficiency (AGHD)
? Idiopathic short stature (ISS)
? Pediatric growth hormone deficiency
? Prader-Willi syndrome (PWS)
? Small for gestational age (SGA)
? Turner syndrome (TS)
? Others
PART 9. MARKET BREAKDOWN BY REGION
? North America
? Asia Pacific
? Europe
? Rest of the World (ROW)
PART 10. KEY COMPANIES
? Anhui Anke Biotechnology (Group) Co., Ltd.
? Eli Lilly and Company
? F. Hoffmann-La Roche AG
? Ferring B.V.
? Ipsen S.A.
? Merck KGaA
? Novartis AG
? Novo Nordisk A/S
? Pfizer Inc.
? Zhongshan Sinobioway Hygene Biomedicine Co., Ltd.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER